Zum Inhalt springen
Sponsorship
Die MVF-Knowledge-HubsFrisch aus der Forschung. Täglich aktualisiert!

Suchen Sie in Hunderten nationaler und internationaler Datenbanken nach dem neuesten Studienwissen der angegebenen Themengebiete und/oder lassen Sie sich werktäglich per Newsletter informieren. Die Newsfeeds werden auf deutsch übersetzt and nach Übertragbarkeit auf das deutsche Gesundheits-/Versorgungssystem ausgewählt:

Zu den Knowledge-Hubs

Top original article

Download PDF TXT - Download CC BY 4.0

Pleitgen: “A real challenge”

Prostate cancer is the most common type of cancer among men in Germany. According to estimates by the Robert Koch Institute, around 67,600 patients become ill every year. Many of those affected have a localized tumor, for which several treatment strategies are possible. The PREFERE study, presented at a press conference in Berlin, is intended to clarify whether one of these options is superior or inferior. But is the study design suitable for this?

Read more
First publication date: 24.01.2013

Downloads

Full article as PDF
Plain text as TXT

Additional Information

Plain Text

>> The PREFERE study recently presented in Berlin is intended, according to Dr. hc Fritz Pleitgen, President of the German Cancer Aid Association and patron of the study, compares the common treatment strategies for early forms of prostate cancer. According to Pleitgen, the aim is to find out whether “the methods are comparably good or whether one therapy is superior to the other”. In this way, the question of the best therapy for each individual should be answered clearly.
A noble goal that will not be easy to achieve.

...

...

Do you want to leave us already?

Subscribe to our newsletter quickly. Then you can be sure that you won't miss anything.